You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.

Business

  • Goldman in deal worth $1.2 billion over US bond claims
      WASHINGTON – Goldman Sachs has agreed to a settlement worth $1.2 billion to resolve claims that it misled U.S.
  • Rib Room building sold; eatery to remain
    The owner of the Rib Room, 1234 E. State Blvd., has sold the building that houses the restaurant to local real estate investors Matt, Kurt and Chris Henry, according to a statement Friday.
  • Yellen sees economy as hazy
    JACKSON HOLE, Wyo. – If anyone thought Janet Yellen might clarify her view of the U.S. job market in her speech Friday, the Federal Reserve chair had a message:
Advertisement
Correction
A headline on a business brief Tuesday about the relationship between DePuy Synthes Cos. and Duke University basketball coach Mike Krzyzewski was inaccurate. The new osteoarthritis awareness campaign will not involve paid advertising. Also, Mindy Tinsley, a DePuy spokeswoman, said the coach does not promote any specific products for DePuy.
Briefs

Duke coach featured in DePuy campaign

The DePuy Synthes Cos. will feature Mike Krzyzewski in a new osteoarthritis awareness campaign, officials said Monday.

The Duke University basketball coach has notched the most wins in men's NCAA Division I basketball history, including four national titles for the Blue Devils. Krzyzewski, 65, has been named national Coach of the Year 12 times. "Coach K" has also coached the men's U.S. Olympic basketball team.

Osteoarthritis, a degenerative joint condition, made movement so painful that Krzyzewski considered leaving the profession in the late 1990s. He opted for DePuy hip replacements, having surgery in 1999 and 2002. Warsaw-based DePuy first struck a spokesman deal with Krzyzewski in 2008, when he agreed to endorse a new line of custom orthopedic implants and instruments.

As part of the osteoarthritis awareness campaign, Krzyzewski and others will share letters of advice they wish they could send to their younger selves. The "Had I Known Then" campaign, which can be accessed online, is scheduled to launch Wednesday.

Delta eyes bigger slice of NY-London travel

The skies between London and New York are full of business travelers, and Delta Air Lines wants more of them.

Delta is looking into buying a big stake in Virgin Atlantic, the second-biggest airline at London's Heathrow airport. New York-to-London is one of the world's most important travel routes, and Delta currently flies fewer flights to Heathrow than its main U.S. competitors, American and United.

On Monday, Singapore Airlines said it is in discussions with "interested parties" to sell its 49 percent stake in Virgin Atlantic. A person with knowledge of the talks told The Associated Press that Delta is in talks with Singapore Airlines about buying the Virgin Atlantic stake.

Archer Daniels ups offer for GrainCorp

Agribusiness conglomerate Archer Daniels Midland Co. is increasing its buyout offer for GrainCorp by almost 4 percent and disclosed it has already added to its stake in the Australian grain handler.

Under the revised bid disclosed Monday, it would cost ADM about $2.33 billion to buy the rest of the company.

ADM said that it owns 19.9 percent of GrainCorp Ltd., up from 14.9 percent when it made its first bid in October.

Cheesemaker Saputo to buy Morningstar

Canadian cheesemaker Saputo Inc. is bolstering its position in the U.S. by pursuing the largest acquisition in its history, a $1.45 billion deal to buy Morningstar Foods.

Montreal-based Saputo said Monday it is expanding U.S. operations by adding dairy and non-dairy products to its current operations as a cheese manufacturer, distributor and exporter. The move effectively replicates the breadth of its operations in Canada, creating a U.S. division of comparable size.

Morningstar employs about 2,000 and has 10 U.S. plants.

Pfizer laying off some sales representatives

Drugmaker Pfizer Inc. is starting another round of layoffs, targeting U.S. sales representatives who promote Pfizer primary care medicines to doctors.

New York-based Pfizer isn't giving details on how many salespeople it employs, how many will leave or when that will happen.

Advertisement